| | |
| Clinical data | |
|---|---|
| Trade names | (none, designer drug) |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C17H12BrClN4 |
| Molar mass | 387.67 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Phenazolam, (Clobromazolam, DM-II-90, BRN 4550445) is a benzodiazepine derivative which acts as a potent sedative and hypnotic drug. It was first invented in the early 1980s, [2] but was never developed for medical use. It has been sold over the internet as a designer drug, first being identified in seized samples by a laboratory in Sweden in March 2016. [3] [4]
Clobromazolam was made illegal in Serbia in May 2019, [5] and in Italy in March 2020. [6]